Application 208912

Type: NDA
Sponsor: EYEPOINT PHARMS

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	DEXYCU KIT	DEXAMETHASONE	SUSPENSION;INTRAOCULAR	9%	Yes	Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N208912-001	DEXYCU KIT	DEXAMETHASONE	9%	SUSPENSION / INTRAOCULAR		RLD	2018-02-09

Orange Book patents#

Current patent rows page 1 of 1 · 5 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N208912-001	10799642	2032-05-11		Drug product	2021-06-11
N208912-001	10028965	2034-05-23	U-2340		2018-08-03
N208912-001	10159683	2034-05-23		Drug product	2019-01-23
N208912-001	10022502	2034-06-22	U-2340		2018-08-03
N208912-001	11097061	2039-06-23	U-3418	Drug product	2022-09-09

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD	2018-02-09	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD	2018-02-09	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N208912-001	DEXYCU KIT	9%	SUSPENSION / INTRAOCULAR	RLD, RS	2018-02-09	`f41ea6bd6efb…`

Observed Orange Book patent history#

Patent history page 1 of 6 · 234 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N208912-001	10799642	2032-05-11		Drug product	2021-06-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208912-001	10028965	2034-05-23	U-2340		2018-08-03	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208912-001	10159683	2034-05-23		Drug product	2019-01-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208912-001	10022502	2034-06-22	U-2340		2018-08-03	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208912-001	11097061	2039-06-23	U-3418	Drug product	2022-09-09	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N208912-001	10799642	2032-05-11		Drug product	2021-06-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208912-001	10028965	2034-05-23	U-2340		2018-08-03	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208912-001	10159683	2034-05-23		Drug product	2019-01-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208912-001	10022502	2034-06-22	U-2340		2018-08-03	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208912-001	11097061	2039-06-23	U-3418	Drug product	2022-09-09	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N208912-001	10799642	2032-05-11		Drug product	2021-06-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208912-001	10028965	2034-05-23	U-2340		2018-08-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208912-001	10159683	2034-05-23		Drug product	2019-01-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208912-001	10022502	2034-06-22	U-2340		2018-08-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208912-001	11097061	2039-06-23	U-3418	Drug product	2022-09-09	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208912-001	10799642	2032-05-11		Drug product	2021-06-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208912-001	10028965	2034-05-23	U-2340		2018-08-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208912-001	10159683	2034-05-23		Drug product	2019-01-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208912-001	10022502	2034-06-22	U-2340		2018-08-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208912-001	11097061	2039-06-23	U-3418	Drug product	2022-09-09	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N208912-001	10799642	2032-05-11		Drug product	2021-06-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N208912-001	10028965	2034-05-23	U-2340		2018-08-03	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N208912-001	10159683	2034-05-23		Drug product	2019-01-23	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N208912-001	10022502	2034-06-22	U-2340		2018-08-03	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N208912-001	11097061	2039-06-23	U-3418	Drug product	2022-09-09	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208912-001	10799642	2032-05-11		Drug product	2021-06-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208912-001	10028965	2034-05-23	U-2340		2018-08-03	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208912-001	10159683	2034-05-23		Drug product	2019-01-23	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208912-001	10022502	2034-06-22	U-2340		2018-08-03	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208912-001	11097061	2039-06-23	U-3418	Drug product	2022-09-09	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208912-001	10799642	2032-05-11		Drug product	2021-06-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208912-001	10028965	2034-05-23	U-2340		2018-08-03	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208912-001	10159683	2034-05-23		Drug product	2019-01-23	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208912-001	10022502	2034-06-22	U-2340		2018-08-03	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208912-001	11097061	2039-06-23	U-3418	Drug product	2022-09-09	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208912-001	10799642	2032-05-11		Drug product	2021-06-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208912-001	10028965	2034-05-23	U-2340		2018-08-03	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208912-001	10159683	2034-05-23		Drug product	2019-01-23	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208912-001	10022502	2034-06-22	U-2340		2018-08-03	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208912-001	11097061	2039-06-23	U-3418	Drug product	2022-09-09	`03ed91905a0d…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N208912-001	NP	2021-02-09	`74a2ff9319b5…`
2021-12-28 21:50 UTC	2021-12	N208912-001	NP	2021-02-09	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N208912-001	NP	2021-02-09	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N208912-001	NP	2021-02-09	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N208912-001	NP	2021-02-09	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N208912-001	NP	2021-02-09	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N208912-001	NP	2021-02-09	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N208912-001	NP	2021-02-09	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N208912-001	NP	2021-02-09	`ea99ee380514…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 5 · 86 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Dexamethasone	DEXAMETHASONE	Preferred Pharmaceuticals Inc.	64577454-d49e-4180-99e6-8461f74b0221	2026-01-20	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
DEXAMETHASONE	DEXAMETHASONE	Bryant Ranch Prepack	075717e3-be2a-4bb3-bead-492761bfb287	2026-01-09	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
Hemady	DEXAMETHASONE	Edenbridge Pharmaceuticals LLC.	6b9cf32c-6d60-4853-bbfd-2304ffc2c129	2026-01-09	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
Dexamethasone	DEXAMETHASONE	Northwind Health Company, LLC	aa30086a-8551-413e-9cf2-6393093cfcfd	2025-12-26	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
Dexamethasone	DEXAMETHASONE	Golden State Medical Supply, Inc.	a7455c92-41ce-4e87-e053-2995a90a610f	2025-12-11	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
DEXAMETHASONE	DEXAMETHASONE	PD-Rx Pharmaceuticals, Inc.	a8d6792e-757e-4dc6-adf5-0d9211075428	2025-12-09	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
Dexamethasone	DEXAMETHASONE	ANI Pharmaceuticals, Inc.	5d9b22ca-c619-4ee3-98eb-74544d0d5cb3	2025-12-04	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
Dexamethasone	DEXAMETHASONE	Kesin Pharma Corporation	43e2a24a-4465-5787-e063-6394a90a0b81	2025-11-18	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
DEXAMETHASONE	DEXAMETHASONE	Kanchan Healthcare Inc	02f7bf9c-1aa3-4734-8a3e-1f49498055d7	2025-11-12	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
Dexamethasone	DEXAMETHASONE	Proficient Rx LP	429d0d32-a1ff-481b-b4e9-c0b17b3610a1	2025-11-01	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
Dexamethasone	DEXAMETHASONE	Advanced Rx Pharmacy of Tennessee, LLC	01cfaa3e-5e30-18fa-e063-6394a90a084e	2025-10-29	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
DEXAMETHASONE	DEXAMETHASONE	Advagen Pharma Ltd.	3c1729db-8ba3-4cba-9eff-ab4ae2c061c2	2025-10-22	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
Dexamethasone	DEXAMETHASONE	PD-Rx Pharmaceuticals, Inc.	2ceb3a01-f5bb-4538-b5c1-cea400901d02	2025-10-15	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
Dexamethasone	DEXAMETHASONE	Apotex Corp.	bfaa71cb-e517-8d94-f64b-8cdbf7b8fbf2	2025-09-17	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
dexamethasone	DEXAMETHASONE	Major Pharmaceuticals	5ec5b0e6-7fa8-4afc-97a4-d185484ada8b	2025-09-08	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
Dexamethasone	DEXAMETHASONE	Rising Pharma Holdings, Inc.	7cf5c17c-a80b-4547-83b2-0d53e2b933f7	2025-09-05	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
Dexamethasone	DEXAMETHASONE	A-S Medication Solutions	16c59e9a-8e4f-4300-bbbb-bcc982c18fc8	2025-08-15	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
Dexamethasone	DEXAMETHASONE	A-S Medication Solutions	89af5591-eebf-44e7-827f-ce3b123123e4	2025-08-15	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
Dexamethasone	DEXAMETHASONE	NuCare Pharmaceuticals,Inc.	141e16a7-1f3d-3943-e063-6294a90ac5a9	2025-07-30	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE
Dexamethasone Intensol	DEXAMETHASONE INTENSOL	Hikma Pharmaceuticals USA, Inc.	b15200fb-1826-472b-a907-e677a272513b	2025-06-06	Warnings, Adverse reactions	Name fallback generic name: DEXAMETHASONE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 4 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
71879-001	Dexycu	dexamethasone	EyePoint Pharmaceuticals US, Inc	NDA	Current
71879-001	Dexycu	dexamethasone	EyePoint Pharmaceuticals US, Inc	NDA	Current
71879-001	Dexycu	dexamethasone	EyePoint Pharmaceuticals US, Inc	NDA	Current
71879-001	Dexycu	dexamethasone	EyePoint Pharmaceuticals US, Inc	NDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
63429	SUPPL	2020-06-08
63424	SUPPL	2020-06-05
55861	ORIG	2018-10-10
52548	ORIG	2018-02-09
52529	ORIG	2018-02-09